Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARK2 pseudogene 16 (MARK2P16) is a human pseudogene related to the protein-coding gene Microtubule Affinity Regulating Kinase 2 (MARK2)[1]. Pseudogenes are generally considered non-functional copies or remnants of functional genes, sometimes transcribed but not translated into active protein[6][7][3][4]. Some pseudogenes can exert regulatory effects on their parent genes, e.g., via RNA-mediated interactions, but there is no specific evidence that MARK2P16 is therapeutically actionable or has direct clinical significance[1][3][4][5][6]. In the context of the olfactory gene network, MARK2P16 is notable because its parent gene MARK2 is involved in neuronal polarity and migration, including in the olfactory bulb[1][2]. However, MARK2P16 itself is not a receptor, enzyme, transporter, or other classical drug target and does not appear in drug or biomarker databases. Notes and Rationale: - is_incorrect: true because this is not a protein, enzyme, receptor, transporter, or actionable therapeutic target but a pseudogene. Pseudogenes like MARK2P16 may have indirect regulatory roles, but are not conventional drug targets[1][3][5][6]. - The information about its function is inferential, tied to the general emerging understanding that pseudogenes may act as gene expression regulators via RNA mechanisms, but this is not established as a direct function for MARK2P16[1][3][5][6]. - No aliases, disease roles, or safety concerns are documented for this specific pseudogene. - All specific therapeutic target fields are null, as no drugs target pseudogenes like MARK2P16. In summary, MARK2 pseudogene 16 is a non-protein-coding pseudogene, not an actionable therapeutic target, and is only relevant as a genomic and possible gene regulatory element through mechanisms established for pseudogenes in general[1][3][5][6].
Not applicable; no known small-molecule or biologic interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARK2 pseudogene 16 (MARK2P16).